These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16909399)

  • 1. Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene.
    Tosic M; Ott J; Barral S; Bovet P; Deppen P; Gheorghita F; Matthey ML; Parnas J; Preisig M; Saraga M; Solida A; Timm S; Wang AG; Werge T; Cuénod M; Do KQ
    Am J Hum Genet; 2006 Sep; 79(3):586-92. PubMed ID: 16909399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No association between glutathione-synthesis-related genes and Japanese schizophrenia.
    Hanzawa R; Ohnuma T; Nagai Y; Shibata N; Maeshima H; Baba H; Hatano T; Takebayashi Y; Hotta Y; Kitazawa M; Arai H
    Psychiatry Clin Neurosci; 2011 Feb; 65(1):39-46. PubMed ID: 21105962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation screening of the glutamate cysteine ligase modifier (GCLM) gene in patients with schizophrenia.
    Butticaz C; Werge T; Beckmann JS; Cuénod M; Do KQ; Rivolta C
    Psychiatr Genet; 2009 Aug; 19(4):201-8. PubMed ID: 19455074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of glutamate cysteine ligase modifier (GCLM) gene and schizophrenia in Han Chinese.
    Ma J; Li DM; Zhang R; Yang XD; Gao CG; Lu SM; Wu SN; Wang L
    Schizophr Res; 2010 Jun; 119(1-3):273-4. PubMed ID: 20061124
    [No Abstract]   [Full Text] [Related]  

  • 5. Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence.
    Gysin R; Kraftsik R; Sandell J; Bovet P; Chappuis C; Conus P; Deppen P; Preisig M; Ruiz V; Steullet P; Tosic M; Werge T; Cuénod M; Do KQ
    Proc Natl Acad Sci U S A; 2007 Oct; 104(42):16621-6. PubMed ID: 17921251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamate cysteine ligase modifier (GCLM) subunit gene is not associated with methamphetamine-use disorder or schizophrenia in the Japanese population.
    Kishi T; Ikeda M; Kitajima T; Yamanouchi Y; Kinoshita Y; Kawashima K; Inada T; Harano M; Komiyama T; Hori T; Yamada M; Iyo M; Sora I; Sekine Y; Ozaki N; Ujike H; Iwata N
    Ann N Y Acad Sci; 2008 Oct; 1139():63-9. PubMed ID: 18991850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial characterization of the glutamate-cysteine ligase modifier subunit Gclm(-/-) knockout mouse. Novel model system for a severely compromised oxidative stress response.
    Yang Y; Dieter MZ; Chen Y; Shertzer HG; Nebert DW; Dalton TP
    J Biol Chem; 2002 Dec; 277(51):49446-52. PubMed ID: 12384496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association and expression studies of glutamate-cysteine ligase modifier (GCLM) and schizophrenia in the Chinese Han population.
    Che R; Tang W; Shao L; Zhao Q; Huang K; Tang R; Li Z; Zhao X; Ji W; Zhou G; Feng G; He L; Shi Y
    Psychiatr Genet; 2009 Oct; 19(5):279-80. PubMed ID: 19584774
    [No Abstract]   [Full Text] [Related]  

  • 9. Alterations in glutamate cysteine ligase content in the retina of two retinitis pigmentosa animal models.
    Sánchez-Vallejo V; Benlloch-Navarro S; Trachsel-Moncho L; López-Pedrajas R; Almansa I; Romero FJ; Miranda M
    Free Radic Biol Med; 2016 Jul; 96():245-54. PubMed ID: 27140233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic dysregulation of glutathione synthesis predicts alteration of plasma thiol redox status in schizophrenia.
    Gysin R; Kraftsik R; Boulat O; Bovet P; Conus P; Comte-Krieger E; Polari A; Steullet P; Preisig M; Teichmann T; Cuénod M; Do KQ
    Antioxid Redox Signal; 2011 Oct; 15(7):2003-10. PubMed ID: 20673128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mice lacking the glutamate-cysteine ligase modifier subunit are susceptible to myocardial ischaemia-reperfusion injury.
    Kobayashi T; Watanabe Y; Saito Y; Fujioka D; Nakamura T; Obata JE; Kitta Y; Yano T; Kawabata K; Watanabe K; Mishina H; Ito S; Kugiyama K
    Cardiovasc Res; 2010 Mar; 85(4):785-95. PubMed ID: 19837697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin fibroblast model to study an impaired glutathione synthesis: consequences of a genetic polymorphism on the proteome.
    Gysin R; Riederer IM; Cuénod M; Do KQ; Riederer BM
    Brain Res Bull; 2009 Apr; 79(1):46-52. PubMed ID: 19041695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants in glutamate cysteine ligase confer protection against type 2 diabetes.
    Azarova I; Klyosova E; Lazarenko V; Konoplya A; Polonikov A
    Mol Biol Rep; 2020 Aug; 47(8):5793-5805. PubMed ID: 32715377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Polymorphism Associated Prefrontal Glutathione and Its Coupling With Brain Glutamate and Peripheral Redox Status in Early Psychosis.
    Xin L; Mekle R; Fournier M; Baumann PS; Ferrari C; Alameda L; Jenni R; Lu H; Schaller B; Cuenod M; Conus P; Gruetter R; Do KQ
    Schizophr Bull; 2016 Sep; 42(5):1185-96. PubMed ID: 27069063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamate-cysteine ligase modifier subunit: mouse Gclm gene structure and regulation by agents that cause oxidative stress.
    Solis WA; Dalton TP; Dieter MZ; Freshwater S; Harrer JM; He L; Shertzer HG; Nebert DW
    Biochem Pharmacol; 2002 May; 63(9):1739-54. PubMed ID: 12007577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamate Cysteine Ligase Modifier Subunit (Gclm) Null Mice Have Increased Ovarian Oxidative Stress and Accelerated Age-Related Ovarian Failure.
    Lim J; Nakamura BN; Mohar I; Kavanagh TJ; Luderer U
    Endocrinology; 2015 Sep; 156(9):3329-43. PubMed ID: 26083875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin, quercetin, and tBHQ modulate glutathione levels in astrocytes and neurons: importance of the glutamate cysteine ligase modifier subunit.
    Lavoie S; Chen Y; Dalton TP; Gysin R; Cuénod M; Steullet P; Do KQ
    J Neurochem; 2009 Mar; 108(6):1410-22. PubMed ID: 19183254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism in the 5'-flanking region of human glutamate-cysteine ligase modifier subunit gene is associated with myocardial infarction.
    Nakamura S; Kugiyama K; Sugiyama S; Miyamoto S; Koide S; Fukushima H; Honda O; Yoshimura M; Ogawa H
    Circulation; 2002 Jun; 105(25):2968-73. PubMed ID: 12081989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of early psychosis patients carrying a genetic vulnerability to redox dysregulation: a computational analysis of mechanism-based gene expression profile in fibroblasts.
    Giangreco B; Dwir D; Klauser P; Jenni R; Golay P; Cleusix M; Baumann PS; Cuénod M; Conus P; Toni N; Do KQ
    Mol Psychiatry; 2023 May; 28(5):1983-1994. PubMed ID: 37002404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral phenotyping of glutathione-deficient mice: relevance to schizophrenia and bipolar disorder.
    Kulak A; Cuenod M; Do KQ
    Behav Brain Res; 2012 Jan; 226(2):563-70. PubMed ID: 22033334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.